To increase AD specificity, we used frozen postmortem hippocampal samples obtained from a cohort of pure AD cases showing only deposits of phosphorylated tau and β-amyloid along with controls free of any protein inclusion. The gene discussed is MAPT; the disease is Alzheimer disease.